Australian access to FDA-approved breakthrough therapy designation medicines: a 10-year review by Senthil Lingaratnam, Safeera Yasmeen Hussainy, Alexandra Murphy, Cale Perrin, Melbin Samuvel, Elahe Mehrvarz, Chiao Xin Lim, John Zalcberg

Connect to this object online.

A qualitative investigation of the supportive care experiences of people living with pancreatic and oesophagogastric cancer by Nadia N. Khan, Ashika Maharaj, Sue Evans, Charles Pilgrim, John Zalcberg, Wendy Brown, Paul Cashin, Daniel Croagh, Natasha Michael, Jeremy Shapiro, Kate White, Liane Ioannou

Connect to this object online.

Incorporating patient-reported outcome measures (PROMs) into a clinical quality registry (CQR) for ovarian cancer: considerations and challenges by Yael R Lefkovits, Natalie Heriot, Alice Sporik, Sharnel Perera, Michael Friedlander, Cyril Dixon, Paul A Cohen, Yeh Chen Lee, Simon Hyde, Gary Richardson, Penelope Webb, Robert Rome, Madeleine King, John Zalcberg, Penelope Schofield

Connect to this object online.

What, Where, and How to Collect Real-World Data and Generate Real-World Evidence to Support Drug Reimbursement Decision-Making in Asia: A reflection Into the Past and A Way Forward by Sarin Kc, Lydia Wenxin Lin, Diana Beatriz Samson Bayani, Yaroslava Zemlyanska, Amanda Adler, Jeonghoon Ahn, Kelvin Chan, Dechen Choiphel, Anne Julienne Genuino-Marfori, Brendon Kearney, Yuehua Liu, Ryota Nakamura, Fiona Pearce, Shankar Prinja, Raoh-Fang Pwu, Arsul Akmal Shafie, Binyan Sui, Auliya Suwantika, Sean Tunis, Hui-Min Wu, John Zalcberg, Kun Zhao, Wanrudee Isaranuwatchai, Yot Teerawattananon, Hwee-Lin Wee

Connect to this object online.